Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Berkley Renewables Inc C.BKS

Berkley Renewables Inc. is a Canada-based growth-oriented diversified issuer also pursuing renewable energy opportunities, primarily in the solar energy sector. The Company is pursuing solar energy investments in Ontario, Canada. It is also engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function through RepliCel Life Sciences Inc. (RepliCel). RepliCel's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin and pattern baldness. RepliCel is also developing an injection device (RCI) for optimal clinical delivery. It is developing solar photovoltaic (PV) projects in Ontario, Canada, through its subsidiary, Solar Flow-Through General Partnership. Working with Solar Flow-Through, the Company has also developed a flow-through investment vehicle for investors to participate in Ontario's solar energy growth.


CSE:BKS - Post by User

Comment by tradewatcherson Dec 19, 2007 8:22am
249 Views
Post# 14043855

RE: Berkley – future doubtful

RE: Berkley – future doubtfulThe Nature of Operations and Going Concern Note you mention was also in last years Financial Statements.  The Sept.30/97 Interim Statements filed on SEDAR on Nov.29/07 state in Note 10 page 13 that the Company is still short $950,000 in exploration expenditures renounced to investors under the tax flow-through look back rule and that the Company has until December 31, 2007 to incur the expenses.  With only $160,000 in the bank, it's unlikely the Company will meet the deadline.  If the expenses are not incurred, the Company must issue an amended tax receipt reducing the amount previously renounced and the investors will be required to amend their tax returns. The Company will receive significant penalties and interest charges.  The Company raised another $1,400,000 in flow-through funds this year but only $242,000 in general working capital.  The management and director fees of $252,000 exceeded the amount raised in general working capital.  So where is the money coming from to continue operations? The bottom line is that we'll see more selling off assets and/or borrowing more money to raise enough funds to clean up the financial mess this company is in.
<< Previous
Bullboard Posts
Next >>